Theravance Biopharma, Inc. (16) | Business Finance (5)

Browse by Subcategory

Recent Contracts

Registration Rights Agreement among Theravance Biopharma, Inc., GSK Finance (No.3) plc and GlaxoSmithKline plc dated June 22, 2020 (Filed With SEC on June 25, 2020)
Form of Note Purchase Agreement, dated February 21, 2020 by and among Theravance Biopharma R&D, Inc., Triple Royalty Sub II LLC, and the Purchasers (Filed With SEC on February 27, 2020)
Underwriting Agreement among Theravance Biopharma, Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC, as representatives of the several underwriters,... (Filed With SEC on February 13, 2020)
Agreement and General Release between Theravance Biopharma US, Inc. and Shehnaaz Suliman, dated March 1, 2019 (Filed With SEC on May 10, 2019)
Waiver and Assignment of Registration Rights and Voting Agreement among GSK Finance (No.3) plc, Glaxo Group Limited and Theravance Biopharma, Inc. dated as of June 22, 2020 (Filed With SEC on June 25, 2020)